Sparta Commercial Services (SRCO) 10-Q 19 Sep 22 2023 Q1 Quarterly report Financial data

Cover

Cover - shares	3 Months Ended
	Jul. 31, 2022	Sep. 19, 2022
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Jul. 31, 2022
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2023
Current Fiscal Year End Date	--04-30
Entity File Number	0-9483
Entity Registrant Name	SPARTA COMMERCIAL SERVICES, INC.
Entity Central Index Key	0000318299
Entity Tax Identification Number	30-0298178
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	555 Fifth Avenue
Entity Address, Address Line Two	14th Floor
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10017
City Area Code	(212)
Local Phone Number	239-2666
Title of 12(b) Security	Common stock, $.001 par value
Trading Symbol	SRCO
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		18,378,048

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Jul. 31, 2022	Apr. 30, 2022
Current Assets
Cash and cash equivalents	$ 870	$ 317
Accounts receivable	3,351
Inventory	8,116	8,422
Other current assets
Total Current Assets	12,337	8,739
Property and equipment, net of accumulated depreciation and amortization of $213,262 and $213,262, respectively
Other assets
Deposits	9,000	9,000
Total assets	21,337	17,739
Current Liabilities
Bank overdraft	63,784	27,202
Accounts payable and accrued expenses	4,430,181	4,354,129
Short Term Loan	141,585	141,585
Current portion notes payable	5,310,084	5,250,084
Deferred revenue	12,566	13,385
Derivative liabilities	7,873,782	9,549,640
Total Current Liabilities	17,831,982	19,336,025
Loans payable-related parties	439,803	432,403
Total Long Term Liabilities	439,803	432,403
Total liabilities	18,271,785	19,768,428
Stockholders’ Deficit:
Common stock, $0.001 par value; 750,000,000 shares authorized, and 17,301,298 and 15,128,005 shares issued and outstanding, respectively	17,301	15,128
Common stock to be issued 10,741,576 and 1,214,528 respectively	10,116	8,292
Additional paid-in-capital	53,601,950	53,210,921
Accumulated deficit	(72,883,335)	(73,984,686)
Total deficiency in stockholders’ equity	(19,238,547)	(20,734,864)
Non-controlling interest	988,099	984,175
Total Deficit	(18,250,448)	(19,750,689)
Total Liabilities and Deficit	21,337	17,739
Series A convertible preferred stock [Member]
Stockholders’ Deficit:
Preferred stock value	12,500	12,500
Series B convertible preferred stock [Member]
Stockholders’ Deficit:
Preferred stock value
Series C Convertible Preferred Stock [Member]
Stockholders’ Deficit:
Preferred stock value	2,303	2,363
Series D redeemable convertible preferred stock [Member]
Stockholders’ Deficit:
Preferred stock value	$ 618	$ 618

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($)	Jul. 31, 2022	Apr. 30, 2022
Accumulated depreciation and amortization	$ 213,262	$ 213,262
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares designated	10,000,000	10,000,000
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	750,000,000	750,000,000
Common stock shares issued	17,301,298	15,128,005
Common stock shares outstanding	17,301,298	15,128,005
Common stock to be issued	10,741,576	1,214,528
Series A convertible preferred stock [Member]
Preferred stock, par value	$ 100	$ 100
Preferred stock, shares designated	35,850	35,850
Preferred stock, shares issued	125	125
Preferred stock, shares outstanding	125	125
Series B convertible preferred stock [Member]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares designated	1,000	1,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Preferred stock, liquidation and redemption value per share	$ 10,000	$ 10,000
Series C redeemable convertible preferred stock [Member]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares designated	200,000	200,000
Preferred stock, shares issued	4,145	4,145
Preferred stock, shares outstanding	4,145	4,145
Preferred stock, liquidation and redemption value per share	$ 10	$ 10
Series D redeemable convertible preferred stock [Member]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares designated	2,000,000	2,000,000
Preferred stock, shares issued	1,494	4,494
Preferred stock, shares outstanding	1,494	4,494
Preferred stock, liquidation and redemption value per share	$ 1	$ 1

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Jul. 31, 2022	Jul. 31, 2021
Revenue
Total Revenue	$ 68,953	$ 60,685
Less Cost of goods sold	11,043	10,177
Gross profit	57,910	50,508
Operating expenses:
General and administrative	530,913	250,024
Research and Development	41,969
Total operating expenses	572,882	250,024
Loss from operations	(514,972)	(199,516)
Other (income) expense:
Other income
Forgiveness of debt
Financing cost	1,025	180,750
Amortization of debt discount
Loss (gain) in changes in fair value of derivative liability	(1,621,272)	(760,068)
Total other (income) expense	(1,620,247)	(579,318)
Net income (loss)	1,105,275	379,802
Net profit attributable to minority shareholder	(3,924)	338
Preferred dividend
Net income (loss) attributed to common stockholders	$ 1,101,351	$ 380,140
Basic and diluted loss per share:
Net income (loss) attributable to Sparta Commercial Services, Inc. common stockholders	$ 0.07	$ 0.03
Weighted average shares outstanding	16,340,345	10,912,112
Information Technology [Member]
Revenue
Total Revenue	$ 63,467	$ 56,557
New World Health Brands [Member]
Revenue
Total Revenue	$ 5,486	$ 4,128

Condensed Consolidated Statem_2

Condensed Consolidated Statements Deficits - USD ($)	3 Months Ended
	Jul. 31, 2022	Jul. 31, 2021
Beginning Balance	$ (19,750,689)	$ (12,625,931)
Conversion of Preferred to common shares	$ 9,940
Conversion of Preferred to common shares, shares	60,000
Issuance of Preferred and Common Stock for Cash		373,801
Conversion of notes to common shares		25,000
Issuance of preferred shares
Issuance of common shares for cash	94,999	99,318
Shares issued for services	$ 245,381
Issuance of shares for services, shares	1,594,960
Stocks issued for equity	$ 44,647
Stocks issued for equity, shares	518,333
Conversion of convertible notes
Preferred dividend
Net loss	$ 1,105,275	380,140
Ending Balance	(18,250,448)	(11,747,672)
Common Stock [Member]
Beginning Balance	$ 15,128	$ 9,810
Beginning balance, shares	15,128,005	9,809,877
Conversion of Preferred to common shares	$ 60
Conversion of Preferred to common shares, shares	60,000
Issuance of Preferred and Common Stock for Cash		$ 1,574
Issuance of Preferred and Common Stock for Cash, shares		1,574,001
Conversion of notes to common shares		$ 125
Conversion of notes to common shares, shares		125,000
Shares issued for services	$ 1,595
Issuance of shares for services, shares	1,594,960
Stocks issued for equity	$ 518
Stocks issued for equity, shares	518,333
Net loss
Ending Balance	$ 17,301	$ 11,509
Ending balance, shares	17,301,298	11,508,878
Common Stock to be Issued [Member]
Beginning Balance	$ 8,292	$ 1,215
Beginning balance, shares	8,916,805	1,214,528
Issuance of common shares for cash	$ 1,824	$ 1,135
Issuance of common shares for cash, shares	1,824,771	1,134,697
Net loss
Ending Balance	$ 10,116	$ 2,350
Ending balance, shares	10,741,576	2,349,225
Additional Paid-in Capital [Member]
Beginning Balance	$ 53,210,921	$ 51,351,156
Conversion of Preferred to common shares	9,940
Issuance of Preferred and Common Stock for Cash		373,234
Conversion of notes to common shares		24,875
Issuance of common shares for cash	93,175	98,183
Shares issued for services	243,786
Stocks issued for equity	44,128
Net loss
Ending Balance	53,601,950	51,847,448
Retained Earnings [Member]
Beginning Balance	(73,984,686)	(64,993,250)
Net loss	1,101,351	379,802
Ending Balance	(72,883,335)	(64,613,448)
Noncontrolling Interest [Member]
Beginning Balance	984,175	986,999
Conversion of notes to common shares
Net loss	3,924	338
Ending Balance	988,099	987,337
Series A Preferred Stock [Member] | Preferred Stock [Member]
Beginning Balance	$ 12,500	$ 12,500
Beginning balance, shares	125	125
Net loss
Ending Balance	$ 12,500	$ 12,500
Ending balance, shares	125	125
Series C Preferred Stock [Member] | Preferred Stock [Member]
Beginning Balance	$ 2,363	$ 4,145
Beginning balance, shares	2,163,000	4,132,269
Conversion of Preferred to common shares	$ (60)
Conversion of Preferred to common shares, shares	(60,000)
Issuance of Preferred and Common Stock for Cash		$ (704)
Issuance of Preferred and Common Stock for Cash, shares		(704,300)
Net loss
Ending Balance	$ 2,303	$ 3,441
Ending balance, shares	2,103,000	3,427,969
Series D Preferred Stock [Member] | Preferred Stock [Member]
Beginning Balance	$ 618	$ 1,494
Beginning balance, shares	618,411	1,494,962
Issuance of Preferred and Common Stock for Cash		$ (303)
Issuance of Preferred and Common Stock for Cash, shares		(1,303,551)
Net loss
Ending Balance	$ 618	$ 1,191
Ending balance, shares	618,411	191,411

Condensed Consolidated Statem_3

Condensed Consolidated Statements Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Jul. 31, 2022	Jul. 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	$ 1,105,275	$ 379,802
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Loss (Gain) from change in fair value of derivative liabilities	(1,675,858)	(760,028)
Amortization of debt discount		40,000
Non-cash financing cost	518	18,250
Forgiveness of debt
Stock based compensation	242,448	25,000
Changes in operating assets and liabilities
Accounts receivable	(45,320)	(1,328)
Inventory	306	1,573
Other assets
Accounts payable and accrued expenses	83,452	225,595
Deferred revenue	(819)	(475)
Net cash used in operating activities	(248,029)	(71,611)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of equipment
Net cash (used in) investing activities
CASH FLOWS FROM FINANCING ACTIVITIES
Bank overdraft	36,582	17,058
Proceeds from sale of stock	152,000	70,000
Net Proceeds from notes payable	60,000
Payments on notes payable		(15,000)
Proceeds from related party notes
Payments on related party notes
Net cash provided by financing activities	248,582	72,058
Net (decrease) increase in cash	553	447
Cash and cash equivalents, beginning of period	317	396
Cash and cash equivalents , end of period	870	843
Cash paid for:
Income taxes

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	3 Months Ended
	Jul. 31, 2022
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE A – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES A summary of the significant accounting policies applied in the preparation of the accompanying unaudited condensed consolidated financial statements follows. Business General Overview Sparta Commercial Services, Inc. (“Sparta,” “we,” “us,” or the “Company”) is a Nevada corporation with headquarters in New York City, www.spartacommercial.com www.spartacommercial.com Sparta’s roots are in the Powersports industry. The Company provided retail installment loans and leases through authorized motorcycle dealerships in 33 states, with financing provided by institutional lenders. The Company also maintained a full underwriting and servicing platform for its portfolio. Notwithstanding the discontinuance of our initial focus on consumer loans and leases post Lehman and during the 2008 financial crisis; in 2007, the Company had introduced a new initiative, Municipal Financing, ( www.spartamunicipal.com Vehicle History Reports are a staple of Sparta’s E-Commerce Technology subsidiary iMobile Solutions, Inc. Whether a vehicle is intended for business or recreational use, Sparta’s Vehicle History Reports are highly regarded for accuracy and completeness and have been sold across all 50 states and in 62 countries worldwide. They provide a trusted layer of assurance to vehicle buyers and are available on Kelley Blue Book, AllState Insurance and a range of various dealership websites. They include Cyclechex (Motorcycle History Reports at www.cyclechex.com www.rvchex.com www.truckchex.com The Company’s E-Commerce and Mobile Technology subsidiary name change to iMobile Solutions, Inc., from Specialty Reports, Inc., in 2016, signifies its ever-broadening service offerings in the evolving technology landscape. With iMobile App ( www.imobileapp.com www.imobileapp.com/app-gallery Sparta created its subsidiary, New World Health Brands, Inc., in April 2019, on the heels of the Agriculture Improvement Act (also known as the Farm Bill), which was signed into law the previous December 20, 2018. Consequently, hemp (CBD) was removed from Schedule 1 of the Controlled Substances Act. Company management recognized the substantial business opportunity that lay ahead in the rapidly expanding hemp-CBD (cannabidiol) market in the United States. During 2019-2020, we sourced, developed and tested 5 CBD product categories totaling 31 products. We procured premium, domestic-grade, full-spectrum, broad-spectrum, and THC free hemp, created product packaging and labelling, and implemented fulfilment to launch an online B to C website: www.newworldhealthcbd.com Sparta’s response to the onset of the COVID 19 pandemic in early 2020 quickly took shape with thorough investigations into evolving customer trends in health and wellness. As a result, we expanded New World Health Brands and developed a new product line of natural dietary supplements. In August 2020, we launched an online B to C website: www.newworldhealthbrands.com Sparta’s newest subsidiary, Sparta Crypto, Inc., www.SpartaCrypto.com, was established September 25, 2020 and is in the process of completing a proprietary state-of-the-art platform designed to connect users of widely adopted digital currencies with sellers of various goods and services. The platform has not launched and the Company can make no assurances that the described plan will reach implementation. In addition, the Company has completed and tested a cryptocurrency payment gateway called SpartaPayIQ, www.SpartaPayIQ.com Basis of Presentation The accompanying unaudited condensed consolidated financial statements as of July 31, 2022 and for the three months ended July 31, 2022 and 2021 have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission, including Form 10-Q and Regulation S-K. The information furnished herein reflects all adjustments (consisting of normal recurring accruals and adjustments), which are, in the opinion of management, necessary to fairly present the operating results for the respective periods. Certain information and footnote disclosures normally present in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been omitted pursuant to such rules and regulations. The Company believes that the disclosures provided are adequate to make the information presented not misleading. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and explanatory notes for the year ended April 30, 2022 as disclosed in the Company’s Form 10-K for that year as filed with the Securities and Exchange Commission on August 15, 2022. The results of operations for the three months ended July 31, 2022 are not necessarily indicative of the results to be expected for any other interim period or the full year ending April 30, 2023. The condensed consolidated balance sheet as of April 30, 2022 contained herein has been derived from the audited consolidated financial statements as of April 30, 2022, but do not include all disclosures required by the U.S. GAAP. Principles of Consolidation The consolidated financial statements include the accounts of the Company and its majority owned subsidiaries. All material intercompany transactions and balances have been eliminated in consolidation. The third-party ownership of the Company’s subsidiary is accounted for as noncontrolling interest in the consolidated financial statements. Changes in the noncontrolling interest are reported in the statement of changes in deficit. Estimates These financial statements have been prepared in accordance with accounting principles generally accepted in United States of America which require management to make estimates and assumptions that affect the reported amounts of assets, liabilities, and the disclosures of revenues and expenses for the reported period. Accordingly, actual results could differ from those estimates. Revenue Recognition During the first quarter of 2018, the Company adopted ASU 2014-09, Revenue from Contracts with Customers (Topic 606) The Company acts as a principal in its revenue transactions as the Company is the primary obligor in the transactions. Revenues from mobile app products and New World Health Brands products are generally recognized upon delivery. Revenues from History Reports are generally recognized upon delivery / download. Prepayments received from customers before delivery (if any) are recognized as deferred revenue and recognized upon delivery. The Company records deferred revenues when cash payments are received or due in advance of our performance, including amounts which are refundable. Cash Equivalents For the purpose of the accompanying financial statements, all highly liquid investments with a maturity of three months or less are considered to be cash equivalents. Fair Value Measurements The Company has adopted ASC 820, “Fair Value Measurements .” ● Level 1 — ● Level 2 — ● Level 3 — This hierarchy requires the Company to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value. For some products or in certain market conditions, observable inputs may not always be available. Income Taxes We utilize ASC 740 “ Income Taxes The Company recognizes the impact of a tax position in the financial statements only if that position is more likely than not of being sustained upon examination by taxing authorities, based on the technical merits of the position. Our practice is to recognize interest and/or penalties related to income tax matters in income tax expense. Stock Based Compensation We account for our stock-based compensation under ASC 718 “ Compensation – Stock Compensation We use the fair value method for equity instruments granted to non-employees and use the Black-Scholes model for measuring the fair value of options. The stock based fair value compensation is determined as of the date of the grant or the date at which the performance of the services is completed (measurement date) and is recognized over the vesting periods. Inventories The Company’s inventories represent finished goods, consist of products available for sale and are accounted for using the first-in, first-out (FIFO) method and valued at the lower of cost or net realizable value. Inventory consists of finished goods for the Company’s New World Health business. Property and Equipment Property and equipment are recorded at cost. Minor additions and renewals are expensed in the year incurred. Major additions and renewals are capitalized and depreciated over their estimated useful lives. Depreciation is calculated using the straight-line method over the estimated useful lives. Estimated useful lives of major depreciable assets are as follows: SCHEDULE OF ESTIMATED USEFUL LIFE OF PROPERTY AND EQUIPMENT Leasehold improvements 3 years Furniture and fixtures 7 years Website costs 3 years Computer Equipment 5 years Concentrations of Credit Risk Financial instruments and related items, which potentially subject the Company to concentrations of credit risk, consist primarily of cash, cash equivalents and receivables. The Company places its cash and temporary cash investments with high credit quality institutions. At times, such investments may be in excess of the FDIC insurance limit. Net Loss Per Share The Company uses ASC 260-10, “ Earnings Per Share As of July 31, 2022 and 2021, approximately 42,000,000 10,741,576 2,349,225 Derivative Liabilities The Company assessed the classification of its derivative financial instruments as of July 31, 2022 and April 30, 2022, which consist of convertible instruments and rights to shares of the Company’s common stock and determined that such derivatives meet the criteria for liability classification under ASC 815. ASC 815 generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as freestanding derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional, as described. Convertible Instruments The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with professional standards for “ Accounting for Derivative Instruments and Hedging Activities The Company accounts for convertible instruments (when it has determined that the embedded conversion options should not be bifurcated from their host instruments) in accordance with professional standards when “ Accounting for Convertible Securities with Beneficial Conversion Features Reclassifications Certain reclassifications have been made to conform to prior periods’ data to the current presentation. These reclassifications had no effect on reported losses. Recent Accounting Pronouncements In February 2016, the FASB issued Accounting Standards Update No. 2016-02 Leases Leases A variety of proposed or otherwise potential accounting standards are currently under study by standard setting organizations and various regulatory agencies. Due to the tentative and preliminary nature of those proposed standards, we have not determined whether implementation of such proposed standards would be material to our consolidated financial statements.

GOING CONCERN MATTERS

GOING CONCERN MATTERS	3 Months Ended
	Jul. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
GOING CONCERN MATTERS	NOTE B – GOING CONCERN MATTERS The accompanying unaudited condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As shown in the accompanying unaudited condensed consolidated financial statements, the Company has incurred recurring losses and generated negative cash flows from operating activities since inception. As of July 31, 2022, the Company had an accumulated deficit of $ 72,883,335 17,819,645 The Company’s existence is dependent upon management’s ability to develop profitable operations. Management is devoting substantially all of its efforts to developing its business and raising capital and there can be no assurance that the Company’s efforts will be successful. No assurance can be given that management’s actions will result in profitable operations or the resolution of its liquidity problems. The accompanying unaudited condensed consolidated financial statements do not include any adjustments that might result should the Company be unable to continue as a going concern. In order to improve the Company’s liquidity, the Company’s management is actively pursuing additional equity financing through discussions with investment bankers and private investors. There can be no assurance that the Company will be successful in its effort to secure additional equity financing.

NOTES PAYABLE AND DERIVATIVES

NOTES PAYABLE AND DERIVATIVES	3 Months Ended
	Jul. 31, 2022
Debt Disclosure [Abstract]
NOTES PAYABLE AND DERIVATIVES	NOTE C – NOTES PAYABLE AND DERIVATIVES The Company has outstanding numerous notes payable to various parties. The notes bear interest at rates of 5% - 20% per year and are summarized as follows: SCHEDULE OF NOTES PAYABLE Notes Payable July 31, 2022 April 30, 2022 Notes convertible at holder’s option $ 3,112,734 $ 2,980,848 Notes convertible at Company’s option 335,700 335,700 Non-convertible notes payable 1,861,650 1,933,536 Subtotal 5,310,084 5,250,084 Debt discount - Total $ 5,310,084 $ 5,250,084 Certain of the notes payable contain variable conversion rates and the conversion features are classified as derivative liabilities. The conversion prices are based on the market price of the Company’s common stock, at discounts of 30 48 The Company’s derivative financial instruments consist of embedded derivatives related to the outstanding short term Convertible Notes Payable. These embedded derivatives include certain conversion features indexed to the Company’s common stock. The accounting treatment of derivative financial instruments requires that the Company record the derivatives and related items at their fair values as of the inception date of the Convertible Notes Payable and at fair value as of each subsequent balance sheet date. In addition, under the provisions of Accounting Standards Codification subtopic 815-40, Derivatives and Hedging; Contracts in Entity’s Own Equity (“ASC 815-40”), as a result of entering into the Convertible Notes Payable, the Company is required to classify all other non-employee stock options and warrants as derivative liabilities and mark them to market at each reporting date. Any change in fair value inclusive of modifications of terms will be recorded as non-operating, non-cash income or expense at each reporting date. If the fair value of the derivatives is higher at the subsequent balance sheet date, the Company will record a non-operating, non-cash charge. If the fair value of the derivatives is lower at the subsequent balance sheet date, the Company will record non-operating, non-cash income. The change in fair value of the derivative liabilities at July 31, 2022 was calculated with the following average assumptions, using a Black-Scholes option pricing model are as follows: SCHEDULE OF DERIVATIVE LIABILITIES ASSUMPTIONS USING BLACK-SCHOLES OPTION Significant Assumptions: Risk free interest rate Ranging from 0.16 0.2 % Expected stock price volatility Ranging from 155 270 % Expected dividend payout 0 Expected life in years Ranging from 0.25 3.0 Changes in derivative liability during the three months ended July 31, 2022 and 2021 were: SCHEDULE OF CHANGES IN DERIVATIVE LIABILITIES July 31, 2022 2021 Balance, beginning of year $ 9,549,640 $ 3,446,738 Derivative liability extinguished (54,586 ) (385,257 ) Derivative financial liability arising on the issuance of convertible notes and warrants - Fair value adjustments (1,621,272 ) (760,068 ) Balance, end of period $ 7,873,782 $ 2,301,413

LOANS PAYABLE TO RELATED PARTIE

LOANS PAYABLE TO RELATED PARTIES	3 Months Ended
	Jul. 31, 2022
Related Party Transactions [Abstract]
LOANS PAYABLE TO RELATED PARTIES	NOTE D – LOANS PAYABLE TO RELATED PARTIES As of July 31, 2022, and April 30, 2022, aggregated loans and notes payable, without demand and with no interest, to officers and directors were $ 432,403 432,403

EQUITY TRANSACTIONS

EQUITY TRANSACTIONS	3 Months Ended
	Jul. 31, 2022
Equity [Abstract]
EQUITY TRANSACTIONS	NOTE E EQUITY TRANSACTIONS Preferred Stock The Company is authorized to issue 10,000,000 0.001 35,850 100 1,000 10,000 4,200,000 10 2,000,000 1 Common Stock The Company is authorized to issue 750,000,000 0.001 17,301,298 15,128,005 During the three months ended July 31, 2022, the Company: ● Issued 1,594,960 245,381 ● Issued 60,000 20,000 ● Sold to four accredited investors 1,824,771 95,000 57,000 ● Issued 518,333 44,647 to accredited investors related to promissory notes. During the three months ended July 31, 2021, the Company: Sold to four accredited investors 1,134,697 70,000 29,317.81

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS	3 Months Ended
	Jul. 31, 2022
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENTS	NOTE F – FAIR VALUE MEASUREMENTS The Company follows the guidance established pursuant to ASC 820 which established a framework for measuring fair value and expands disclosure about fair value measurements. ASC 820 defines fair value as the amount that would be received for an asset or paid to transfer a liability (i.e., an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes the following three levels of inputs that may be used: Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets and liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs. Level 2: Observable prices that are based on inputs not quoted on active markets but corroborated by market data. Level 3: Unobservable inputs when there is little or no market data available, thereby requiring an entity to develop its own assumptions. The fair value hierarchy gives the lowest priority to Level 3 inputs. The table below summarizes the fair values of financial liabilities as of July 31, 2022: SCHEDULE OF FAIR VALUES OF FINANCIAL LIABILITIES Fair Value at Fair Value Measurement Using July 31, 2022 Level 1 Level 2 Level 3 Derivative liabilities $ 7,873,782 - - $ 7,873,782 Fair values of financial liabilities as of April 30, 2022 are as follows: Fair Value at Fair Value Measurement Using April 30, 2022 Level 1 Level 2 Level 3 Derivative liabilities $ 9,549,640 - - $ 9,549,640 The following is a description of the valuation methodologies used for these items: Derivative liabilities The Company did not identify any other non-recurring assets and liabilities that are required to be presented in the balance sheets at fair value in accordance with ASC Topic 825 “ The Fair Value Option for Financial Issuances

PROPERTY AND EQUIPMENT

PROPERTY AND EQUIPMENT	3 Months Ended
	Jul. 31, 2022
Property, Plant and Equipment [Abstract]
PROPERTY AND EQUIPMENT	NOTE G – PROPERTY AND EQUIPMENT Major classes of property and equipment at July 30, 2022 and April 30, 2022 consist of the followings: SCHEDULE OF PROPERTY AND EQUIPMENT July 31, 2022 April 30, 2022 Computer equipment, software and furniture $ 213,262 $ 213,262 Less: accumulated depreciation (213,262 ) (213,262 ) Net property and equipment $ - $ - All equipment are fully depreciated as of July 30, 2022 and 2021. No additional investment in equipment for both fiscal year.

WARRANTS

WARRANTS	3 Months Ended
	Jul. 31, 2022
Warrants
WARRANTS	NOTE H – WARRANTS No warrants were issued to employees and/ or service. As of July 31, 2022, 3,801,657 228,099

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	3 Months Ended
	Jul. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE I – COMMITMENTS AND CONTINGENCIES Operating Lease Commitments Our executive offices are located in New York, NY. We have an agreement for use of office space at this location under a sub-lease which expired on July 31, 2018 5,100 Rent expense was $ 16,250 16,200 Litigation The Company is subject to legal proceedings and claims which arise in the ordinary course of its business. Sparta can make no representations about the potential outcome of such proceedings. As of July 31, 2022, we have not been named as parties to any further legal proceedings except as those disclosed prior and as updated below. From time to time, of course, we may become involved in further legal proceedings, which sometimes arise due to the very nature of and in the ordinary course of this business. By way of background, the Company had received notices dated April 1, 2016, May 13, 2016 and July 22, 2016 from two lenders claiming defaults relating to conversion requests of $ 8,365.00 5,000.00 55,125.00 27,500.00 With respect to the above claims, on September 22, 2016, a motion for summary judgment in lieu of complaint was filed in the Supreme Court in the State of New York: County of Kings, against the Company by a lender for the amount of $ 102,170.82 On October 26, 2018, a second lender commenced an action in the Supreme Court of the State of New York: New York County alleging damages from unpaid principal arising from a promissory note dated February 26, 2015 in the amount of $ 50,000.00

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	3 Months Ended
	Jul. 31, 2022
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE J – SUBSEQUENT EVENTS The Company has evaluated subsequent events for recognition and disclosure as of September 19, 2022 which is the date the financial statements were available to be issued. No other matters were identified affecting the accompanying financial statements and related disclosures.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	3 Months Ended
	Jul. 31, 2022
Accounting Policies [Abstract]
Business	Business General Overview Sparta Commercial Services, Inc. (“Sparta,” “we,” “us,” or the “Company”) is a Nevada corporation with headquarters in New York City, www.spartacommercial.com www.spartacommercial.com Sparta’s roots are in the Powersports industry. The Company provided retail installment loans and leases through authorized motorcycle dealerships in 33 states, with financing provided by institutional lenders. The Company also maintained a full underwriting and servicing platform for its portfolio. Notwithstanding the discontinuance of our initial focus on consumer loans and leases post Lehman and during the 2008 financial crisis; in 2007, the Company had introduced a new initiative, Municipal Financing, ( www.spartamunicipal.com Vehicle History Reports are a staple of Sparta’s E-Commerce Technology subsidiary iMobile Solutions, Inc. Whether a vehicle is intended for business or recreational use, Sparta’s Vehicle History Reports are highly regarded for accuracy and completeness and have been sold across all 50 states and in 62 countries worldwide. They provide a trusted layer of assurance to vehicle buyers and are available on Kelley Blue Book, AllState Insurance and a range of various dealership websites. They include Cyclechex (Motorcycle History Reports at www.cyclechex.com www.rvchex.com www.truckchex.com The Company’s E-Commerce and Mobile Technology subsidiary name change to iMobile Solutions, Inc., from Specialty Reports, Inc., in 2016, signifies its ever-broadening service offerings in the evolving technology landscape. With iMobile App ( www.imobileapp.com www.imobileapp.com/app-gallery Sparta created its subsidiary, New World Health Brands, Inc., in April 2019, on the heels of the Agriculture Improvement Act (also known as the Farm Bill), which was signed into law the previous December 20, 2018. Consequently, hemp (CBD) was removed from Schedule 1 of the Controlled Substances Act. Company management recognized the substantial business opportunity that lay ahead in the rapidly expanding hemp-CBD (cannabidiol) market in the United States. During 2019-2020, we sourced, developed and tested 5 CBD product categories totaling 31 products. We procured premium, domestic-grade, full-spectrum, broad-spectrum, and THC free hemp, created product packaging and labelling, and implemented fulfilment to launch an online B to C website: www.newworldhealthcbd.com Sparta’s response to the onset of the COVID 19 pandemic in early 2020 quickly took shape with thorough investigations into evolving customer trends in health and wellness. As a result, we expanded New World Health Brands and developed a new product line of natural dietary supplements. In August 2020, we launched an online B to C website: www.newworldhealthbrands.com Sparta’s newest subsidiary, Sparta Crypto, Inc., www.SpartaCrypto.com, was established September 25, 2020 and is in the process of completing a proprietary state-of-the-art platform designed to connect users of widely adopted digital currencies with sellers of various goods and services. The platform has not launched and the Company can make no assurances that the described plan will reach implementation. In addition, the Company has completed and tested a cryptocurrency payment gateway called SpartaPayIQ, www.SpartaPayIQ.com
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements as of July 31, 2022 and for the three months ended July 31, 2022 and 2021 have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission, including Form 10-Q and Regulation S-K. The information furnished herein reflects all adjustments (consisting of normal recurring accruals and adjustments), which are, in the opinion of management, necessary to fairly present the operating results for the respective periods. Certain information and footnote disclosures normally present in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been omitted pursuant to such rules and regulations. The Company believes that the disclosures provided are adequate to make the information presented not misleading. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and explanatory notes for the year ended April 30, 2022 as disclosed in the Company’s Form 10-K for that year as filed with the Securities and Exchange Commission on August 15, 2022. The results of operations for the three months ended July 31, 2022 are not necessarily indicative of the results to be expected for any other interim period or the full year ending April 30, 2023. The condensed consolidated balance sheet as of April 30, 2022 contained herein has been derived from the audited consolidated financial statements as of April 30, 2022, but do not include all disclosures required by the U.S. GAAP.
Principles of Consolidation	Principles of Consolidation The consolidated financial statements include the accounts of the Company and its majority owned subsidiaries. All material intercompany transactions and balances have been eliminated in consolidation. The third-party ownership of the Company’s subsidiary is accounted for as noncontrolling interest in the consolidated financial statements. Changes in the noncontrolling interest are reported in the statement of changes in deficit.
Estimates	Estimates These financial statements have been prepared in accordance with accounting principles generally accepted in United States of America which require management to make estimates and assumptions that affect the reported amounts of assets, liabilities, and the disclosures of revenues and expenses for the reported period. Accordingly, actual results could differ from those estimates.
Revenue Recognition	Revenue Recognition During the first quarter of 2018, the Company adopted ASU 2014-09, Revenue from Contracts with Customers (Topic 606) The Company acts as a principal in its revenue transactions as the Company is the primary obligor in the transactions. Revenues from mobile app products and New World Health Brands products are generally recognized upon delivery. Revenues from History Reports are generally recognized upon delivery / download. Prepayments received from customers before delivery (if any) are recognized as deferred revenue and recognized upon delivery. The Company records deferred revenues when cash payments are received or due in advance of our performance, including amounts which are refundable.
Cash Equivalents	Cash Equivalents For the purpose of the accompanying financial statements, all highly liquid investments with a maturity of three months or less are considered to be cash equivalents.
Fair Value Measurements	Fair Value Measurements The Company has adopted ASC 820, “Fair Value Measurements .” ● Level 1 — ● Level 2 — ● Level 3 — This hierarchy requires the Company to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value. For some products or in certain market conditions, observable inputs may not always be available.
Income Taxes	Income Taxes We utilize ASC 740 “ Income Taxes The Company recognizes the impact of a tax position in the financial statements only if that position is more likely than not of being sustained upon examination by taxing authorities, based on the technical merits of the position. Our practice is to recognize interest and/or penalties related to income tax matters in income tax expense.
Stock Based Compensation	Stock Based Compensation We account for our stock-based compensation under ASC 718 “ Compensation – Stock Compensation We use the fair value method for equity instruments granted to non-employees and use the Black-Scholes model for measuring the fair value of options. The stock based fair value compensation is determined as of the date of the grant or the date at which the performance of the services is completed (measurement date) and is recognized over the vesting periods.
Inventories	Inventories The Company’s inventories represent finished goods, consist of products available for sale and are accounted for using the first-in, first-out (FIFO) method and valued at the lower of cost or net realizable value. Inventory consists of finished goods for the Company’s New World Health business.
Property and Equipment	Property and Equipment Property and equipment are recorded at cost. Minor additions and renewals are expensed in the year incurred. Major additions and renewals are capitalized and depreciated over their estimated useful lives. Depreciation is calculated using the straight-line method over the estimated useful lives. Estimated useful lives of major depreciable assets are as follows: SCHEDULE OF ESTIMATED USEFUL LIFE OF PROPERTY AND EQUIPMENT Leasehold improvements 3 years Furniture and fixtures 7 years Website costs 3 years Computer Equipment 5 years
Concentrations of Credit Risk	Concentrations of Credit Risk Financial instruments and related items, which potentially subject the Company to concentrations of credit risk, consist primarily of cash, cash equivalents and receivables. The Company places its cash and temporary cash investments with high credit quality institutions. At times, such investments may be in excess of the FDIC insurance limit.
Net Loss Per Share	Net Loss Per Share The Company uses ASC 260-10, “ Earnings Per Share As of July 31, 2022 and 2021, approximately 42,000,000 10,741,576 2,349,225
Derivative Liabilities	Derivative Liabilities The Company assessed the classification of its derivative financial instruments as of July 31, 2022 and April 30, 2022, which consist of convertible instruments and rights to shares of the Company’s common stock and determined that such derivatives meet the criteria for liability classification under ASC 815. ASC 815 generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as freestanding derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional, as described.
Convertible Instruments	Convertible Instruments The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with professional standards for “ Accounting for Derivative Instruments and Hedging Activities The Company accounts for convertible instruments (when it has determined that the embedded conversion options should not be bifurcated from their host instruments) in accordance with professional standards when “ Accounting for Convertible Securities with Beneficial Conversion Features
Reclassifications	Reclassifications Certain reclassifications have been made to conform to prior periods’ data to the current presentation. These reclassifications had no effect on reported losses.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In February 2016, the FASB issued Accounting Standards Update No. 2016-02 Leases Leases A variety of proposed or otherwise potential accounting standards are currently under study by standard setting organizations and various regulatory agencies. Due to the tentative and preliminary nature of those proposed standards, we have not determined whether implementation of such proposed standards would be material to our consolidated financial statements.

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	3 Months Ended
	Jul. 31, 2022
Accounting Policies [Abstract]
SCHEDULE OF ESTIMATED USEFUL LIFE OF PROPERTY AND EQUIPMENT	SCHEDULE OF ESTIMATED USEFUL LIFE OF PROPERTY AND EQUIPMENT Leasehold improvements 3 years Furniture and fixtures 7 years Website costs 3 years Computer Equipment 5 years

NOTES PAYABLE AND DERIVATIVES (

NOTES PAYABLE AND DERIVATIVES (Tables)	3 Months Ended
	Jul. 31, 2022
Debt Disclosure [Abstract]
SCHEDULE OF NOTES PAYABLE	The Company has outstanding numerous notes payable to various parties. The notes bear interest at rates of 5% - 20% per year and are summarized as follows: SCHEDULE OF NOTES PAYABLE Notes Payable July 31, 2022 April 30, 2022 Notes convertible at holder’s option $ 3,112,734 $ 2,980,848 Notes convertible at Company’s option 335,700 335,700 Non-convertible notes payable 1,861,650 1,933,536 Subtotal 5,310,084 5,250,084 Debt discount - Total $ 5,310,084 $ 5,250,084
SCHEDULE OF DERIVATIVE LIABILITIES ASSUMPTIONS USING BLACK-SCHOLES OPTION	The change in fair value of the derivative liabilities at July 31, 2022 was calculated with the following average assumptions, using a Black-Scholes option pricing model are as follows: SCHEDULE OF DERIVATIVE LIABILITIES ASSUMPTIONS USING BLACK-SCHOLES OPTION Significant Assumptions: Risk free interest rate Ranging from 0.16 0.2 % Expected stock price volatility Ranging from 155 270 % Expected dividend payout 0 Expected life in years Ranging from 0.25 3.0
SCHEDULE OF CHANGES IN DERIVATIVE LIABILITIES	Changes in derivative liability during the three months ended July 31, 2022 and 2021 were: SCHEDULE OF CHANGES IN DERIVATIVE LIABILITIES July 31, 2022 2021 Balance, beginning of year $ 9,549,640 $ 3,446,738 Derivative liability extinguished (54,586 ) (385,257 ) Derivative financial liability arising on the issuance of convertible notes and warrants - Fair value adjustments (1,621,272 ) (760,068 ) Balance, end of period $ 7,873,782 $ 2,301,413

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	3 Months Ended
	Jul. 31, 2022
Fair Value Disclosures [Abstract]
SCHEDULE OF FAIR VALUES OF FINANCIAL LIABILITIES	The table below summarizes the fair values of financial liabilities as of July 31, 2022: SCHEDULE OF FAIR VALUES OF FINANCIAL LIABILITIES Fair Value at Fair Value Measurement Using July 31, 2022 Level 1 Level 2 Level 3 Derivative liabilities $ 7,873,782 - - $ 7,873,782 Fair values of financial liabilities as of April 30, 2022 are as follows: Fair Value at Fair Value Measurement Using April 30, 2022 Level 1 Level 2 Level 3 Derivative liabilities $ 9,549,640 - - $ 9,549,640

PROPERTY AND EQUIPMENT (Tables)

PROPERTY AND EQUIPMENT (Tables)	3 Months Ended
	Jul. 31, 2022
Property, Plant and Equipment [Abstract]
SCHEDULE OF PROPERTY AND EQUIPMENT	Major classes of property and equipment at July 30, 2022 and April 30, 2022 consist of the followings: SCHEDULE OF PROPERTY AND EQUIPMENT July 31, 2022 April 30, 2022 Computer equipment, software and furniture $ 213,262 $ 213,262 Less: accumulated depreciation (213,262 ) (213,262 ) Net property and equipment $ - $ -

SCHEDULE OF ESTIMATED USEFUL LI

SCHEDULE OF ESTIMATED USEFUL LIFE OF PROPERTY AND EQUIPMENT (Details)	3 Months Ended
	Jul. 31, 2022
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Computer Equipment	3 years
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Computer Equipment	7 years
Website Costs [Member]
Property, Plant and Equipment [Line Items]
Computer Equipment	3 years
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Computer Equipment	5 years

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - shares	3 Months Ended
	Jul. 31, 2022	Jul. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	42,000,000	42,000,000
Shares to be Issued [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	10,741,576	2,349,225

GOING CONCERN MATTERS (Details

GOING CONCERN MATTERS (Details Narrative) - USD ($)	Jul. 31, 2022	Apr. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Retained earnings (accumulated deficit)	$ 72,883,335	$ 73,984,686
Working capital deficit	$ 17,819,645

SCHEDULE OF NOTES PAYABLE (Deta

SCHEDULE OF NOTES PAYABLE (Details) - USD ($)	Jul. 31, 2022	Apr. 30, 2022
Short-Term Debt [Line Items]
Subtotal	$ 5,310,084	$ 5,250,084
Debt discount
Total	5,310,084	5,250,084
Notes Convertible At Holders Option [Member]
Short-Term Debt [Line Items]
Subtotal	3,112,734	2,980,848
Notes Convertible At Companys Option [Member]
Short-Term Debt [Line Items]
Subtotal	335,700	335,700
Non Convertible Notes Payable [Member]
Short-Term Debt [Line Items]
Subtotal	$ 1,861,650	$ 1,933,536

SCHEDULE OF DERIVATIVE LIABILIT

SCHEDULE OF DERIVATIVE LIABILITIES ASSUMPTIONS USING BLACK-SCHOLES OPTION (Details)	3 Months Ended
	Jul. 31, 2022
Measurement Input, Risk Free Interest Rate [Member] | Minimum [Member]
Debt Instrument [Line Items]
Derivative liability, measurement input, expected dividend payout	0.16
Measurement Input, Risk Free Interest Rate [Member] | Maximum [Member]
Debt Instrument [Line Items]
Derivative liability, measurement input, expected dividend payout	0.2
Measurement Input, Price Volatility [Member] | Minimum [Member]
Debt Instrument [Line Items]
Derivative liability, measurement input, expected dividend payout	155
Measurement Input, Price Volatility [Member] | Maximum [Member]
Debt Instrument [Line Items]
Derivative liability, measurement input, expected dividend payout	270
Measurement Input Dividend Payout [Member]
Debt Instrument [Line Items]
Derivative liability, measurement input, expected dividend payout	0
Measurement Input, Expected Term [Member] | Minimum [Member]
Debt Instrument [Line Items]
Derivative liability, measurement input, expected life	3 months
Measurement Input, Expected Term [Member] | Maximum [Member]
Debt Instrument [Line Items]
Derivative liability, measurement input, expected life	3 years

SCHEDULE OF CHANGES IN DERIVATI

SCHEDULE OF CHANGES IN DERIVATIVE LIABILITIES (Details) - USD ($)	3 Months Ended
	Jul. 31, 2022	Jul. 31, 2021
Debt Disclosure [Abstract]
Balance, beginning of year	$ 9,549,640	$ 3,446,738
Derivative liability extinguished	(54,586)	(385,257)
Derivative financial liability arising on the issuance of convertible notes and warrants
Fair value adjustments	(1,621,272)	(760,068)
Balance, end of period	$ 7,873,782	$ 2,301,413

NOTES PAYABLE AND DERIVATIVES_2

NOTES PAYABLE AND DERIVATIVES (Details Narrative)	3 Months Ended
	Jul. 31, 2022
Minimum [Member]
Debt Instrument [Line Items]
Common stock discount rate, percentage	30%
Maximum [Member]
Debt Instrument [Line Items]
Common stock discount rate, percentage	48%

LOANS PAYABLE TO RELATED PART_2

LOANS PAYABLE TO RELATED PARTIES (Details Narrative) - USD ($)	Jul. 31, 2022	Apr. 30, 2022
Related Party Transactions [Abstract]
Loans payable to officers and directors	$ 432,403	$ 432,403

EQUITY TRANSACTIONS (Details Na

EQUITY TRANSACTIONS (Details Narrative) - USD ($)	3 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Apr. 30, 2022
Class of Stock [Line Items]
Preferred stock, shares designated	10,000,000		10,000,000
Preferred stock, par value	$ 0.001		$ 0.001
Common stock, shares authorized	750,000,000		750,000,000
Common stock, par value	$ 0.001		$ 0.001
Common stock shares issued	17,301,298		15,128,005
Common stock shares outstanding	17,301,298		15,128,005
Issuance of stock for service, shares	1,594,960
Issuance of stock for service, value	$ 245,381
Conversion of Preferred to common shares	60,000
Number of shares issued for conversion
Stocks issued for equity, shares	518,333
Stock issued for equity	$ 44,647
Common Stock [Member]
Class of Stock [Line Items]
Issuance of stock for service, shares	1,594,960
Issuance of stock for service, value	$ 1,595
Conversion of Preferred to common shares	60,000
Issuance of shares for cash	1,824,771
Issuance of shares for cash, value	$ 95,000
Stocks issued for equity, shares	518,333
Stock issued for equity	$ 518
Common Stock [Member] | Four Accredited Investors [Member]
Class of Stock [Line Items]
Number of stocks sold during period		1,134,697
Sale of stock		$ 70,000
Settlement notes payable and accrued expenses		$ 29,317.81
Common Stock [Member] | iMobile Solutions, Inc. [Member]
Class of Stock [Line Items]
Number of shares issued for conversion	$ 57,000
Series A convertible preferred stock [Member]
Class of Stock [Line Items]
Preferred stock, shares designated	35,850		35,850
Preferred stock, par value	$ 100		$ 100
Series B convertible preferred stock [Member]
Class of Stock [Line Items]
Preferred stock, shares designated	1,000		1,000
Preferred stock, par value	$ 0.001		$ 0.001
Preferred stock, liquidation and redemption value per share	$ 10,000		$ 10,000
Series C Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares designated	4,200,000
Number of shares converted during the period	20,000
Series C redeemable convertible preferred stock [Member]
Class of Stock [Line Items]
Preferred stock, shares designated	200,000		200,000
Preferred stock, par value	$ 0.001		$ 0.001
Preferred stock, liquidation and redemption value per share	$ 10		$ 10
Series D redeemable convertible preferred stock [Member]
Class of Stock [Line Items]
Preferred stock, shares designated	2,000,000		2,000,000
Preferred stock, par value	$ 0.001		$ 0.001
Preferred stock, liquidation and redemption value per share	$ 1		$ 1

SCHEDULE OF FAIR VALUES OF FINA

SCHEDULE OF FAIR VALUES OF FINANCIAL LIABILITIES (Details) - USD ($)	Jul. 31, 2022	Apr. 30, 2022	Jul. 31, 2021	Apr. 30, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities	$ 7,873,782
Derivative liabilities	7,873,782	$ 9,549,640	$ 2,301,413	$ 3,446,738
Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities
Derivative liabilities
Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities
Derivative liabilities
Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities	$ 7,873,782
Derivative liabilities		$ 9,549,640

SCHEDULE OF PROPERTY AND EQUIPM

SCHEDULE OF PROPERTY AND EQUIPMENT (Details) - USD ($)	Jul. 31, 2022	Apr. 30, 2022
Property, Plant and Equipment [Line Items]
Less: accumulated depreciation	$ (213,262)	$ (213,262)
Net property and equipment
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Computer equipment, software and furniture	$ 213,262	$ 213,262

WARRANTS (Details Narrative)

WARRANTS (Details Narrative) - Warrant [Member] - USD ($)	3 Months Ended	12 Months Ended
	Jul. 31, 2022	Apr. 30, 2022
Warrants vested	3,801,657
Fair value adjustment of warrants		$ 228,099

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)		3 Months Ended
	Sep. 22, 2016	Jul. 31, 2022	Jul. 31, 2021	Feb. 26, 2015
Rent expenses		$ 16,250	$ 16,200
Promissory Note [Member]
Aggregate note amount				$ 50,000
New York County Kings [Member]
Loss on contingent	$ 102,170.82
Lender One [Member]
Debt principal amount		8,365
Aggregate note amount		55,125
Lender Two [Member]
Debt principal amount		5,000
Aggregate note amount		$ 27,500
Executive Office Space [Member]
Lease expiring date		Jul. 31, 2018
Rent expenses		$ 5,100